OGN
Organon & Co.
Organon & Co. (OGN) has 2 SEC Form 4 filings (3 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: May 7, 2026.
- Industry:Drug Manufacturers - General
- CEO:Joseph T. Morrissey Jr.
- Employees:10,000
- HQ:Jersey City, NJ, US
- IPO:2021-05-14
Insider Buying
$353K
reported purchases (SEC code P)
Insider Selling
$353K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$3.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| SVP and Corporate Controller | Sale | 26,448.366 | $353K | May 7 | SEC ↗ | |
Holzbaur LynetteFirst filing | SVP and Corporate Controller | Purchase | 26,448.366 | $353K | May 7 | SEC ↗ |
Related companies
Organon & Co. is in the Healthcare sector.